The evidence highlighted that METTL3 enhanced LDHA expression, catalyzing the conversion of pyruvate to lactate, thereby promoting glycolysis and enhancing chemotherapy tolerance to 5-FU in tumor cells. This evidence concerns the gene LDHA and neoplasm.